Related Experiment Video
Updated: Jun 13, 2025

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Clinical correlates of medication adherence in individuals with bipolar disorder and comorbid hypertension
Jennifer B Levin1, David J Moore2, Farren Briggs3
1Department of Psychiatry and Neurological & Behavioral Outcomes Center, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Insights
Medication adherence in bipolar disorder (BD) and hypertension (HTN) patients impacts health outcomes. Better adherence to BD medications correlated with higher psychiatric symptoms, while antihypertensive adherence improved blood pressure control.
Area of Science:
- Psychiatry
- Cardiology
- Pharmacology
Background:
- Individuals with bipolar disorder (BD) often experience poor medication adherence, leading to increased medical illness and premature mortality, particularly from cardiovascular causes.
- Comorbid hypertension (HTN) in BD patients exacerbates these risks, highlighting the need to understand medication adherence in this population.
Purpose of the Study:
- To examine the association between adherence to antihypertensive medications, adherence to BD medications, and clinical symptoms in patients with BD and comorbid HTN.
- To investigate how different measurement methods impact the assessment of medication adherence.
Main Methods:
- Included 83 participants with BD and HTN, assessing adherence via self-report (Tablets Routine Questionnaire) and electronic monitoring (eCAP).
- Measured average systolic blood pressure (SBP) from 12 readings and BD symptoms using the Montgomery-Asberg Depression Rating Scale (MADRS) and Brief Psychiatric Rating Scale (BPRS).
Main Results:
- Adherence to BD medications and antihypertensives were positively correlated.
- Electronic monitoring (eCAP) revealed more missed antihypertensive doses than self-reports.
- Antihypertensive adherence correlated negatively with SBP, and this adherence improved while SBP decreased from screening to baseline.
Conclusions:
- Medication adherence levels varied over time and by measurement method in patients with comorbid BD and HTN.
- Self-reported BD medication adherence was linked to higher psychiatric symptom severity.
- Antihypertensive adherence was associated with better SBP control, and monitoring both medication and blood pressure influenced self-reported adherence.
Objective:
Individuals with bipolar disorder (BD) have high rates of suboptimal medication adherence, medical illness, and premature mortality, largely from cardiovascular causes. This study examined the association between adherence to antihypertensive, adherence to BD medications, and clinical symptoms in patients with BD and comorbid hypertension (HTN). Participants were involved in an ongoing clinical trial.
Method:
Inclusion criteria were a BD diagnosis, treatment with antihypertensives, adherence challenges, and poorly controlled HTN. Adherence was measured via self-report using the Tablets Routine Questionnaire and using eCAP, an electronic pill bottle that captures openings. Average systolic blood pressure (SBP) was calculated from 12 readings over one week. The Montgomery-Asberg Depression Rating Scale (MADRS) and the Brief Psychiatric Rating Scale (BPRS) assessed BD symptoms.
Results:
A total of 83 participants with BD and HTN were included. Adherence to BD medications and antihypertensive medications were positively correlated. eCAP openings showed more missed doses than participants self-reported for antihypertensive adherence. BD medication adherence was positively correlated with BPRS at baseline, whereas antihypertensive adherence was negatively correlated with SBP at screening. Antihypertensive adherence improved and SBP decreased between screening and baseline.
Conclusions:
Adherence levels fluctuated over time and differed based on measurement method in participants with comorbid BD and HTN. Self-reported BD adherence was positively related to global psychiatric symptoms and antihypertensive adherence was related to better SBP control. Monitoring both medication and blood pressure led to a change in self-reported adherence. BD symptom severity may interfere with medication adherence in patients with BD and should be considered in treatment planning.
More Related Videos
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
05:57Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Related Concept Videos
Mania and Antimanic Drugs: Overview
Bipolar Disorder
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Hypertension and Regulation of Blood Pressure
Psychosis and Antipsychotic Drugs: Overview